Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
03/2014
03/26/2014CN103665004A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664995A Naphthodithiophene derivative organic electroluminescent material and application thereof
03/26/2014CN103664992A Compounds for treating ischemic brain injury and application thereof
03/26/2014CN103664973A Spiro-oxindole compounds and their use as therapeutic agents
03/26/2014CN103664962A Piperazines derivative
03/26/2014CN103664748A Pyrene compound and organic light emitting diode device including the same
03/26/2014CN102746325B Compound 1,10-N-decylene lycorine dibromo salt, pharmaceutical composition and application thereof in medicine
03/26/2014CN102372730B Bridged ring substituted phosphodiesterase inhibitor
03/20/2014WO2014042163A1 Novel compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device
03/20/2014WO2014040373A1 Pi3k and/or mtor inhibitor
03/19/2014EP2708540A1 Pyrimido-diazepinone compound
03/19/2014CN103649067A Fused heterocyclic aromatic derivative, organic electroluminescence element material, and organic electroluminescence element using same
03/19/2014CN103642004A Polymeric semiconductor containing fluoro benzothiadiazole, its preparation method and its application
03/19/2014CN103641849A Adipic acid bridging molecular tweezer series porphyrin compounds and preparation method thereof
03/19/2014CN102746304B Purinamine compound and preparation method thereof
03/19/2014CN102276632B Praziquantel derivative as well as preparation and application thereof
03/13/2014WO2014039899A1 Pyrazolopyrimidine compounds as kinase inhibitors
03/13/2014WO2014037750A1 Inhibitor compounds
03/13/2014US20140073790 Novel fluoroergoline analogs
03/12/2014CN103635478A Novel cephem compound having catechol or pseudo-catechol structure
03/12/2014CN103635473A Dispiropyrrolidine derivative
03/12/2014CN103626775A DPP-4 inhibitor with diazine structure
03/12/2014CN103623610A Method for extracting dinophysistoxins-1 and yessotoxin-2 from seawater and purifying dinophysistoxins-1 and yessotoxin-2
03/12/2014CN102326273B Organic electroluminescent element
03/12/2014CN101998958B Thieno-and furo-pyrimidine modulators of histamine H4 receptor
03/12/2014CN101935303B Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/06/2014WO2014032498A1 Highly selective c-met inhibitors as anticancer agents
03/06/2014WO2013190510A3 NOVEL 2,3-DIHYDRO-1H-IMIDAZO{1,2-a}PYRIMIDIN-5-ONE and this1,2,3,4-TETRAHYDROPYRIMIDO{1,2-a}PYRIMIDIN-6-ONE DERIVATIVES COMPRISING A SUBSTITUTED MORPHOLINE, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF
03/06/2014US20140066450 Novel fluoroergoline analogs
03/05/2014EP2704225A1 Organic electroluminescent element
03/05/2014EP2703406A1 Novel cephem compound having catechol or pseudo-catechol structure
03/05/2014EP2701510A1 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
03/05/2014CN103619855A Diketopyrrolopyrrole oligomers for use in organic semiconductor devices
02/2014
02/27/2014WO2014030743A1 Heterocycic compound
02/27/2014WO2014029732A1 Pyrrolo[2,3-b]pyrazines as syk inhibitors
02/27/2014US20140057924 Bivalent inhibitors of iap proteins and therapeutic methods using the same
02/27/2014US20140057896 Pyridone and aza-pyridone compounds and methods of use
02/27/2014CA2876543A1 Pyrrolo[2,3-b]pyrazines as syk inhibitors
02/26/2014EP2699617A1 Conjugated polymers
02/26/2014EP2699579A1 Pyrazolo [4, 3-d]pyrimidines useful as kinase inhibitors
02/26/2014EP2699576A1 Pyrazolospiroketone derivatives for use as acetyl - coa carboxylase inhibitors
02/26/2014EP2699571A2 Materials for organic electroluminescent devices
02/26/2014CN103608347A 咪唑并吡啶化合物 Imidazopyridine compound
02/26/2014CN102382129B Spirocycles-substituted phosphodiesterase inhibitor
02/26/2014CN102131810B Diketone fused azolopiperidines and azolopiperazines as anti-HIV agents
02/26/2014CN102050831B Cephalosporin derivative
02/26/2014CN101918407B Beta-lactamase inhibitors
02/20/2014WO2014027913A1 Catalyst for fixation of molecular nitrogen
02/20/2014WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
02/20/2014US20140051689 Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections
02/19/2014EP2698370A2 3-substituted-4-oxo-3,4-dihydro-imidazo-[5,1-d][1,2,3,5]-tetrazine-8-carboxylic acid amides as anticancer agents
02/19/2014EP2697224A1 Naphthalene-diimide-heterocycle-naphthalene diimide oligomers as organic semiconductors and transistors therefrom
02/19/2014CN103588959A Naphthalene tetracarboxyldiimide copolymer containing thienopyrroledione unit, and preparation method and application thereof
02/19/2014CN103588792A Pyrazolopyrimidine or pyrimidinopyrimidine compounds, preparation method therefor, pharmaceutical compositions thereof and applications thereof
02/13/2014WO2014023814A1 New antibacterial compounds
02/13/2014US20140046055 Compounds and methods for inhibiting mitotic progression
02/12/2014EP2694503A1 Substituted oligoazacarbazoles for light emitting diodes
02/12/2014CN103570750A Preparation process of biapenem
02/12/2014CN103570749A Cefozopran preparation technology
02/12/2014CN103570738A Novel artemisinin derivatives and preparation method and use thereof
02/12/2014CN103570722A Fused ring pyridazinone compounds, preparation method and uses thereof
02/12/2014CN103570712A Phosphorescent compound and OLED using the same
02/12/2014CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines
02/12/2014CN103570688A 2,5-diaminomethylpyrazine compounds, drug compositions, preparation method and use thereof
02/06/2014WO2014019966A1 Functionalisation methods and reagents used in such methods using an azaisatoic anhydride or one of the derivatives of same, biological molecules thereby treated, and kits
02/06/2014WO2014019338A1 Protein kinase inhibitors
02/06/2014US20140039188 Novel iso-ergoline derivatives
02/06/2014US20140038941 Ring-fused heterocyclic derivative
02/05/2014EP2692728A1 Novel furanone derivative
02/05/2014CN103562210A Benzoxazepin compounds selective for pi3k p110 delta and methods of use
02/05/2014CN103554140A Preparation method and application of anthraquinone polypyridine ligand and binuclear ruthenium complexes
02/05/2014CN103554104A Azaindoles useful as inhibitors of jak and other protein kinases
02/04/2014US8642653 Ketone compounds and compositions for cholesterol management and related uses
02/04/2014CA2607426C Fused thiazole derivatives as kinase inhibitors
01/2014
01/30/2014WO2014018764A1 Spiro - fused piperidine derivatives for use as inhibitors of the renal outer medullary potassium channel
01/30/2014WO2014016219A1 Dithienobenzofuran polymers and small molecules for electronic application
01/30/2014CA2876508A1 Spiro-fused piperidine derivatives for use as inhibitors of the renal outer medullary potassium channel
01/29/2014EP2688891A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
01/29/2014EP2688887A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
01/29/2014EP2493894B1 Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
01/29/2014EP2078010B1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
01/29/2014CN103547568A Resin-transfer-moldable terminal-modified imide oligomer using 2-phenyl-4,4'-diaminodiphenyl ether and having excellent moldability, mixture thereof, varnish containing same, and cured resin thereof and fiber-reinforced cured resin thereof made by re
01/29/2014CN103539784A Heterocyclic benzamide compounds, pharmaceutical compositions as well as application thereof
01/29/2014CN102363622B Compound and preparation method and use thereof
01/29/2014CN101835779B Purine derivatives useful as PI3 kinase inhibitors
01/23/2014WO2014014885A1 Novel methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1 r,5s) -3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide
01/22/2014EP2687533A2 Acrylamide derivatives as FAB I inhibitors
01/22/2014EP2687529A1 Condensed heterocyclic compound
01/22/2014EP2687508A1 Resin-transfer-moldable terminal-modified imide oligomer using 2-phenyl-4,4'-diaminodiphenyl ether and having excellent moldability, mixture thereof, varnish containing same, and cured resin thereof and fiber-reinforced cured resin thereof made by resin transfer molding and having excellent heat resistance
01/22/2014EP2686321A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
01/22/2014EP2685981A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
01/21/2014US8633185 Pyrrolobenzodiazepines
01/16/2014WO2014011568A1 Azaindole derivatives which act as pi3k inhibitors
01/16/2014WO2014009317A1 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications
01/16/2014WO2014009295A1 Imidazopyridine derivatives as modulators of tnf activity
01/16/2014CA2877550A1 Imidazopyridine derivatives as modulators of tnf activity
01/15/2014EP2684880A1 Dispiropyrrolidine derivative
01/15/2014EP2683722A1 Fluorophenyl bicyclic heteroaryl compounds
01/15/2014EP2683716A1 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
01/15/2014CN103509036A Novel fused ring compound and organic light-emitting device including the same
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 111